While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.
As Eli Lilly has surged to become the most valuable company in biopharma—with a market cap now more than twice that of ...
Eli Lilly is pouring another $4.5 billion into expanding drug manufacturing and development. The diabetes treatment maker ...
In addition to internships at Eskenazi, the program has funded summer internships at major Indianapolis employers, including ...
Eli Lilly (LLY) announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and ...